Wikisage, the free encyclopedia of the second generation, is digital heritage
Levetiracetam: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
m (→Links: neurotherapeutics) |
||
| Line 4: | Line 4: | ||
==Links== | ==Links== | ||
In | In myoclonic astatic epilepsy should be used with caution in children<ref>Paradoxical exacerbation of myoclonic-astatic seizures by levetiracetam in myoclonic astatic epilepsy. BMC paediatrics 15 6</ref> | ||
===ATC=== | ===ATC=== | ||
{| style="background:Ivory; color:black" border=1 cellspacing=1 cellpadding=5 | {| style="background:Ivory; color:black" border=1 cellspacing=1 cellpadding=5 | ||
| Line 21: | Line 22: | ||
Jackson J.-L. et al.2015 | Jackson J.-L. et al.2015 | ||
*[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501738/ A Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache] | *[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501738/ A Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache] | ||
Caviness J. N. | |||
[http://www.ncbi.nlm.nih.gov/pubmed/24037428 Treatment of myoclonus] | |||
{{Wikidata|Q417227}} | {{Wikidata|Q417227}} | ||
Revision as of 00:34, 30 March 2016
(S)-2-(2-Oxopyrrolidin-1-yl)butanamide is an anticonvulsant medication used to treat epilepsy. It is the S-enantiomer of etiracetam, structurally similar to the prototypical nootropic drug piracetam.
Extended release
Links
In myoclonic astatic epilepsy should be used with caution in children[1]
ATC
Trinka E., et al 2015 Pharmacotherapy for Status Epilepticus Drugs 75:1499
Safraski J.-P.2015
Jackson J.-L. et al.2015
Caviness J. N. Treatment of myoclonus
- ↑ Paradoxical exacerbation of myoclonic-astatic seizures by levetiracetam in myoclonic astatic epilepsy. BMC paediatrics 15 6
- ↑ http://www.whocc.no/atc_ddd_index/?code=N03AX14&showdescription=yes